database
Cofactor Quickly Moving Immunotherapy Predictive Test to Market With Data From Intermountain Spinout
Premium
Culmination Bio's 4.5 million biospecimens and longitudinal omics and clinical data may help Cofactor rapidly advance the OncoPrism assay into multiple cancer types.
Cota, Genomic Testing Cooperative Ink Precision Oncology Partnership
The firms will combine real-world patient outcomes and clinical information with DNA and RNA sequencing data to help researchers advance personalized treatment approaches.
Castle Biosciences Working With NCI on SEER Registry Study of DecisionDx-Melanoma
A first data analysis has shown patients with DecisionDx-Melanoma testing had better overall survival rates than those who were not tested.
FDA Recognizes Portion of MSK Oncology Knowledge Base in Public Human Genetic Variant Database
MSK's OncoKB is the first collection of somatic variants that the FDA has accepted for test developers to use in premarket validation studies.
In particular, the diagnostics company expects the new resource to strengthen its offerings to pharmaceutical partners, a key customer group.